These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24505033)

  • 1. Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo.
    Schwab I; Mihai S; Seeling M; Kasperkiewicz M; Ludwig RJ; Nimmerjahn F
    Eur J Immunol; 2014 May; 44(5):1444-53. PubMed ID: 24505033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
    Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.
    Leontyev D; Katsman Y; Branch DR
    Blood; 2012 May; 119(22):5261-4. PubMed ID: 22508937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.
    Schwab I; Seeling M; Biburger M; Aschermann S; Nitschke L; Nimmerjahn F
    Eur J Immunol; 2012 Dec; 42(12):3302-9. PubMed ID: 22945870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.
    Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production.
    Tjon AS; van Gent R; Jaadar H; Martin van Hagen P; Mancham S; van der Laan LJ; te Boekhorst PA; Metselaar HJ; Kwekkeboom J
    J Immunol; 2014 Jun; 192(12):5625-34. PubMed ID: 24808368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.
    Campbell IK; Miescher S; Branch DR; Mott PJ; Lazarus AH; Han D; Maraskovsky E; Zuercher AW; Neschadim A; Leontyev D; McKenzie BS; Käsermann F
    J Immunol; 2014 Jun; 192(11):5031-8. PubMed ID: 24760152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
    Fuchs S; Feferman T; Meidler R; Brenner T; Laub O; Souroujon MC
    Isr Med Assoc J; 2008 Jan; 10(1):58-60. PubMed ID: 18300576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweetened antibodies against humoral autoimmunity: sialylated antibodies are required for IVIg-mediated therapy.
    Fillatreau S
    Eur J Immunol; 2014 May; 44(5):1276-80. PubMed ID: 24700289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
    Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.
    Tackenberg B; Nimmerjahn F; Lünemann JD
    J Clin Immunol; 2010 May; 30 Suppl 1():S65-9. PubMed ID: 20424898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin.
    Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV
    Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?
    Lamoureux J; Aubin E; Lemieux R
    Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
    Schwab I; Nimmerjahn F
    Nat Rev Immunol; 2013 Mar; 13(3):176-89. PubMed ID: 23411799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the cellular immune system by intravenous immunoglobulin.
    Tha-In T; Bayry J; Metselaar HJ; Kaveri SV; Kwekkeboom J
    Trends Immunol; 2008 Dec; 29(12):608-15. PubMed ID: 18926775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.